Antibodies to Phosphatidylserine/Prothrombin (aPS/PT) Are An Independent Risk Factor for Thrombosis in Patients with Systemic Lupus Erythematosus (SLE)

被引：0
|
作者：
Bertolaccini, Maria Laura [1 ]
Sciascia, Savino [1 ]
Murru, Veronica [1 ]
Garcia-Fernandez, Cesar [1 ]
Sanna, Giovanni [2 ]
Khamashta, Munther A. [1 ]
机构：
[1] Kings Coll London, Sch Med, Rayne Inst, Lupus Res Unit, London WC2R 2LS, England
[2] St Thomas Hosp, Louise Coote Lupus Unit, London, England
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
25
引用
收藏
页码：S9 / S10
页数：2
相关论文
共 50 条
  • [1] The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus
    Nojima, Junzo
    Iwatani, Yoshinori
    Suehisa, Etsuji
    Kuratsune, Hirohiko
    Kanakura, Yuzuru
    [J]. HAEMATOLOGICA, 2006, 91 (05) : 699 - 702
  • [2] History of Lupus Nephritis Is an Independent Risk Factor for Thrombosis in Systemic Lupus Erythematosus Patients with Antiphospholipid Antibodies
    Domingues, Vinicius
    Nwaukoni, Janet
    Buyon, Jill P.
    Belmont, H. Michael
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity
    Zhang, Yuncong
    Su, Yang
    Guo, Han
    Wang, Lu
    Li, Aiwei
    Wang, Chanjuan
    Zhang, Jie
    Qiao, Rui
    [J]. CLINICAL BIOCHEMISTRY, 2023, 112 : 17 - 23
  • [4] Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome
    Sciascia, Savino
    Sanna, Giovanni
    Murru, Veronica
    Roccatello, Dario
    Khamashta, Munther A.
    Bertolaccini, Maria Laura
    [J]. THROMBOSIS AND HAEMOSTASIS, 2014, 111 (02) : 354 - 364
  • [5] ANTI-PHOSPHATIDYLSERINE/PROTHROMBIN COMPLEX ANTIBODIES (APS/PT) INCREASE THE RISK FOR THROMBOSISBASED ON LUPUS ANTICOAGULANTPOSITIVITY
    Su, Yang
    Zhang, Yuncong
    Guo, Han
    Guo, Wanwan
    Liu, Cheng
    Qiao, Rui
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 109 - 109
  • [6] RISK FACTORS FOR THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Mahaparn, P.
    Uaprasert, N.
    Rojnuckarin, P.
    [J]. THROMBOSIS RESEARCH, 2014, 133 : S58 - S59
  • [7] The role of anti-phosphatidylserine/prothrombin antibodies in thrombotic manifestations of systemic lupus erythematosus patients
    Tselios, Konstantinos
    Sarantopoulos, Alexandros
    Gkougkourellas, Ioannis
    Boura, Panagiota
    [J]. FRONTIERS IN NEUROLOGY, 2013, 4
  • [8] Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant
    Bertolaccini, Maria Laura
    Sciascia, Savino
    Murru, Veronica
    Garcia-Fernandez, Cesar
    Sanna, Giovanni
    Khamashta, Munther A.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 109 (02) : 207 - 213
  • [9] IS HYPERURICEMIA AN INDEPENDENT RISK FACTOR FOR ARTERIAL THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS?
    Mok, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S103 - S103
  • [10] Is Hyperuricemia an Independent Risk Factor for Arterial Thrombosis in Systemic Lupus Erythematosus?
    Mok, Chi Chiu
    Ho, Ling Yin
    To, Chi Hung
    Chan, Kar Li
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345